AIN
Exymes PLC

Exymes PLC

location_on South East ,  United Kingdom

Please note:
Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investors are encouraged to review and evaluate the investments and determine at their own discretion, the appropriateness of making the particular investment. The information on this website is provided for informational purposes only, but we cannot guarantee that the information is accurate or complete. We strongly encourage investors to complete their own due diligence with licensed professionals, prior to making any investment and will not offer any legal or tax advice.

Short Summary

Enzymatic fast release of stable, patentable and downstreamable DNA and RNA in under 10 minutes. The current annual market size is $1.28 billion.

Highlights

  • Already have accepted products and repeat customers.
  • Excellent highly experienced recognised international team.
  • Already have some very credible high profile respected repeat customers
  • Extremely high margin repeat products
  • All current team members shareholders

Overview

Target ₹238,000,000
Minimum ₹3,000,000
Investment Raised ₹48,000,000
Previous Rounds ₹48,000,000
Stage Achieving Sales
Investor Role Silent

Ask a question
Got a question about this project?

Similar Projects